Company to Provide Broader Access to its AI-Driven Cell-Free Protein Production Platform SAN LEANDRO, Calif. — Tierra Biosciences, the company behind the world’s first platform for predictive AI-guided cell-free technology enabling high-throughput on-demand custom protein synthesis, announced today that it closed an $11.4M Series A round. The investment was led by Material Impact with participation from new […]
Cambridge, Mass. – Vizgen, Inc., the life science company dedicated to improving human health by visualizing single-cell spatial genomics information, has announced a significant capital raise to fuel its continued growth and execution of long-term vision. At the same time, the company has also taken steps to streamline its operations and reduce headcount. These measures […]
CryoCloud, a dutch biotech startup that developed a proprietary data analysis platform, closed a pre-seed round at 500k Euros Their cloud-based cryoEM data analysis platform enables the fast and scalable determination of 3D protein structures used for drug discovery CryoCloud will use the funding to expand the capabilities of its platform to better support scientists […]
Financing led by Sands Capital brings total capital raised to nearly $250 million. Fremont, CA, US – Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, announced today the first close of $100 million in Series C financing with the second close of an additional $28 million expected to happen within […]
Funding through Government of Canada’s Regional Quantum Initiative supports product development and commercialization efforts WATERLOO, ON – High Q Technologies Inc., an innovative life sciences company that develops quantum-enabled scientific instruments for protein characterization in drug discovery, announces a $3.75-million Government of Canada investment, through the Federal Economic Development Agency for Southern Ontario (FedDev Ontario), as part of the Regional Quantum Initiative. The funding will support […]
Company’s synthetic affinity reagents are antibody alternatives designed to advance the speed, safety, and efficiency of manufacturing at scale, making advanced therapies more accessible to patients. Investment led by Mercia Ventures, with Calculus Capital and Angel investors also participating. BEDFORDSHIRE, England–MIP Discovery, an innovative developer of non-biological affinity reagents designed to accelerate the development and […]
2023 marked an important milestone for us, with the move to the new campus. The new building has increased our indoor space in Zizers by approximately 12,000 square meters. On top of that, we have also created almost 50 new jobs worldwide, including around 30 high tech jobs in Graubünden. Despite challenges and global disruptions, […]
$47.5 Million in New Financing Secured from Existing Noteholders, Upsized from Initial $40 million Commitment Supports Mission to Continue Serving Life Sciences Researchers Worldwide SEATTLE —NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced the Company has entered into a credit agreement with its existing […]
Zetta Genomics has expanded its second seed round, attracting new investment and growth expertise. With £6.2 million secured over two years, Zetta scales global operations and customer offerings to transform precision medicine and personalised healthcare. Fast-scaling genomic data pioneer, Zetta Genomics, has expanded its second seed round – securing an additional £1.8 million and strengthening investor expertise. […]
Initiates Voluntary Chapter 11 Restructuring Proceedings with Additional $40 Million in Financing Secured from Existing Noteholders to Facilitate Process Continuing to Serve Life Sciences Researchers Worldwide SEATTLE — NanoString Technologies, Inc. (NASDAQ: NSTG) (“NanoString” or “the Company”), a leading provider of life science tools for discovery and translational research, today announced that steps are being […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
